KennethDavisMD

Psychiatry • New York, NY

Geriatric Psychiatry, Neuropsychiatry, Psychopharmacology

President and Chief Executive Officer of the Mount Sinai Health System and Gustave L. Levy Distinguished Professor

Join to view full profile

Dr. Davis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Davis' full profile

Already have an account?

Office
1425 Madison Avenue
President's Suite
New York, NY 10029
Phone+1 212-659-8888

Fax+1 212-659-9800

Education & Training

Stanford Health Care-Sponsored Stanford UniversityResidency, Psychiatry, 1974 - 1976
Stanford Health CareInternship, Transitional Year, 1973 - 1974
Icahn School of Medicine at Mount SinaiClass of 1973
Yale UniversityB.A., Magna Cum Laude, 1969

Certifications & Licensure

CA State Medical License 1974 - Present
NY State Medical License 1980 - 2025
American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

George H.W. Bush '48 Lifetime of Leadership Award – a distinction given to Yale alumni athletes who make significant breakthroughs in their professions Yale University, 2009
Paul Hoch Distinguished Service Award American College of Neuropsychopharmacology, 2007
"Man of the Year" Award Genetic Disease Foundation, 2007
National Human Relations Centennial Leadership Award American Jewish Committee, 2006
Medical Achievement Award North General Hospital, 2004
Metro Annual Award for Many Accomplishments in the field of Mental Illness NAMI-NYC, 2004
Thomas William Salmon Lecturer, for furthering the understanding of psychiatry, neurology and mental hygiene The New York Academy of Medicine, 2003
Jacobi Medallion, for distinguished achievement in medicine and extraordinary service to the alumni Mount Sinai Hospital, 2002
Elected Member Institute of Medicine, 2001
Award for Research in Psychiatry American Psychiatry Association, 2001
Kempf Fund Award - Research Development in Psychobiological Psychiatry, for Pioneering Developments in Schizophrenia Research 1999
Gold Medal Award, for Outstanding Achievement in Psychobiological Research Society of Biological Psychiatry, 1999
Lifetime Science Award Institute of Advanced Studies in Immunology and Aging, 1992
Rita Hayworth Award Alzheimer's Association, 1991
Daniel H. Efron Award for Excellence in Research in Neuropsychopharmacology ACNP, 1990
Joel Elkes International Award for outstanding research in neuropsycho-pharmacology ACNP, 1986
Solomon Silver Award 1981
Diplomate American Board of Psychiatry and Neurology, 1980
Saul Horowitz, Jr. Memorial Award for Most Outstanding Graduate Mount Sinai School of Medicine, 1977
A.E. Bennett Clinical Science Research Award, for Outstanding Researcher Under Age 35 Society of Biological Psychiatry, 1977
Career Development Award, Research Associate Veterans Administration, 1976
Elster Award for Highest Academic Achievement Mount Sinai School of Medicine, 1973
Alpha Omega Alpha Mount Sinai School of Medicine, 1973
Phi Beta Kappa Yale University, 1969
Exceptional Distinction in Psychology Yale University, 1969
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Publications & Presentations

PubMed

1017 citations
Mapping genomic loci implicates genes and synaptic biology in schizophrenia.
Vassily Trubetskoy, Antonio F Pardiñas, Ting Qi, Georgia Panagiotaropoulou, Swapnil Awasthi
Nature. 2022-04-01
142 citations
Linkage and Association of the Mitochondrial Aspartate/Glutamate Carrier SLC25A12 Gene With Autism
Nicolas Ramoz, Jennifer Reichert, Christopher J. Smith, Jeremy M. Silverman, Irina N. Bespalova
The American Journal of Psychiatry. 2004-04-01
80 citations
Caudate and putamen volumes in good and poor outcome patients with schizophrenia
Monte S. Buchsbaum, Lina Shihabuddin, Adam M. Brickman, Ruben Miozzo, Radovan Prikryl
Schizophrenia Research. 2003-11-01

Journal Articles

Genes and proteins associated with the nodes of Ranvier affect cognition, cortical physiology, and risk of schizophrenia
Roussos P, Katsel P, Davis KL, Bitsios P, Giakoumaki SG, Jogia J, Rozsnyai K, Collier D, Frangou S, Siever L, Haroutunian V, Archives of General Psychiatry, 1/1/2012
A system level transcriptomic analysis in schizophrenia postmortem brain
Roussos P, Katsel P, David KL, Siever LJ, Haroutunian V, Archives of General Psychiatry, 1/1/2012
Molecular and genetic evidence for abnormalities in the nodes of Ravier in schizophrenia
Roussos P, Katsel P, Siever L, David KL, Haroutunian V, Archives of General Psychiatry, 1/1/2012
Save Our Doctors, Don't Cut Graduate Medical Education
Charney DS, Davis KL, NY Times Op-Ed, 6/1/2011
The Right Rx for Hospitals: State's Malpractice Reforms are Long Overdue
Davis KL, New York Daily News, 3/30/2011
Expression of mutant human DISC1 in mice supports abnormalities in differentiation of oligodendrocytes
Katsel P, Tan W, Abazyan B, David KL, Ross C, Pletnikov MV, Haroutunian V, Schizo Res, 1/1/2011
The effects of hypertension and body mass index on diffusion tensor imaging in schizophrenia
Tang CY, Friedman J, Carpenter DM, Novakovic V, Eaves E, Mg J, Wu YW, Gottlieb S, Wallenstein S, Moshier E, Parrella M, White L, Bowler S, McGinn TG, Flanagan L, Davis KL, Schizophrenia Res, 1/1/2011
Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia
Takahashi N, Sakurai T, David KL, Buxbaum JD, Progress in Neurobioogy, 1/1/2011
Pimozide Augmentation of Clozapine Inpatients with Schizophrenia and Schizoaffective Disorder Unresponsive to Clozapine Monotherapy
Friedman JI, Lindenmayer J-P, Alcantara F, Bowler S, Parak M, White L, Iskander A, Parrella M, Adler D, Tsopelas ND, Tsai W-Y, Novakovick V, Harvey P, Davis KL, Neuropsychopharmacology, 1/1/2011
Increased expression of receptor phosphotyrosince phosphatase (PTPRZ1) is associated with molecular, cellcular, behavioral and cognitive schizophrenia phenotypes
Takahashi N, Sakurai T, Bozdagi O, Dorr N, Moy J, Krug L, Gama-Sosa M, Elder G, Koch RJ, Walker RH, Hof PR, Davis KL, Buxbaum J, Translational Psychiatry, 1/1/2011
Fulfilling the Promise of Biomedical Research
Charney DS, Davis KL, NY Times Op-Ed, 4/1/2010
Protecting Urban Academic Medical Centers: An Endangered Species
Davis KL, Charney DS, NY Times Op-Ed, 3/1/2010
Strong Synaptic Transmission Impact by Copy Number Variations in Schizophrenia
Glessner JT, Wang K, Reilly MP, Kim CE, Nagahide T, Albano A, Hou C, Bradfield JP, Zhang H, Sleiman PMA, Flory JH, Imielinski M, Frackelton EC, Chiavacci R, Thomas KA,..., Proceedings of the National Academy of Sciences, 1/1/2010
The Effects of Hypertension and Body Mass Index on Cognition in Schizophrenia
Friedman JI, Wallenstein S, Moshier E, Parrella M, White L, Bowler S, Gottlieb S, Harvey PD, McGinn TG, Flanagan L, Davis KL, American Journal of Psychiatry, 1/1/2010
What Happens When a Combined Entity is Lesser Than the Sum of Its Parts?
Davis KL, Academic Medicine, 1/1/2010
Peripheral Myelin is Expressed in CNS Myelin
De Gasperi R, Gama-Sosa MA, Naumowicz Z, Hof PR, Notterpek L, Davis KL, Buxbaum JD, Elder G, Translational Neuroscience, 1/1/2010
Promises Unfulfilled
Davis KL, NY Times Op-Ed, 4/1/2009
Abnormal cell cycle activity associated with oligodendrocytes in schizophrenia
Katsel P, Tan W, Greenstein E, Davis KL, Haroutunian V, Neuropsychopharmacology, 1/1/2009
Genome-wide linkage analyses of quantitative and categorical autism subphenotypes
Liu XQ, Paterson AD, Szatmari P, Autism Genome Project Consortium, Biol. Psychiatry, 1/1/2008
Schizophrenia and Sex Associated Differences in the Expression of Neuronal and Oligodendrocyte Specific Genes in Individual Thalamic Nuclei
Byne W, Dracheva S, Chin B, Schmeidler JM, Davis KL, Haroutunian V, Schizophrenia Research, 1/1/2008
The Lobotomist
Stewart D, Davis K, American Journal of Psychiatry, 1/1/2008
Temporal Characteristics of Tract-specific Anistropy Abnormalities in Schizophrenia
Carpenter D, Tang C, Friedman J, Hof P, Stewart D, Buchsbaum M, Harvey P, Gorman J, Davis K., NeuroReport, 1/1/2008
CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy
Friedman JI, Vrijenhoek T, Markx S, Janssen IM, Vander V, Faas BH, Knoers NV, Cahn W, Kahn RS, Edelmann L, Davis KL, Siverman JM, Brunner HG, Van Kessel AG, Wijmenga C..., Molecular Psychiatry, 1/1/2008
Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene
Buxbaum JD, Georgieva L, Young JJ, Plescia C, Kajiwara Y, Jiang Y, Moskvina V, Norton N, Peirce T, Williams H, Craddock NJ, Carroll L, Corfas G, Davis KL, Owen MJ, Har..., Mol Psychiatry, 1/1/2008
Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients
Friedman JI, Tang C, Carpenter D, Buchsbaum M, Schmeidler J, Flanagain L, Golmebo S, Kanellopoulou I, Ntg J, Jof PR, Harvey PD, Tsopelas ND, Steward D, Davis KL, Am J Psychiat, 1/1/2008
Join now to see all

Authored Content

President Trump's Budget Should Boost Rather Than Cut Funding for the NIHMay 2017
President Trump's Budget Should Boost Rather Than Cut Funding for the NIHMay 2017

Press Mentions

The Inside Story of CobenfyOctober 3rd, 2024
87 Industry Leaders Reveal Their Secrets to Elevating Patient CareAugust 29th, 2024
New York’s Mount Sinai Health System Opens Concierge Medicine Practice in West Palm BeachMay 15th, 2023
Join now to see all

Grant Support

Project 4 - DTI And MTI Studies In SchizophreniaNational Center For Research Resources2006–2007
White Matter Abnormalities In SchizophreniaNational Institute Of Mental Health2002–2006
Project 4 - Diffusion Tension Imaging (DTI) And Magnetization Transfer ImaginNational Center For Research Resources2005
Project 4 - Diffusion Tension Imaging (DTI) And Magnetization Transfer Imagin...National Center For Research Resources2004
General Clinical Research CenterNational Center For Research Resources2003–2004
Facility Renovation And Annenberg CAGE WASH FacilitiyNational Center For Research Resources2003
Magnetization Transfer And Diffusion Tensor ImagingNational Institute Of Mental Health2002
Alpha 2 Agonist PLUS A Cholinesterase Inhibitor In Alzheimers DiseaseNational Institute On Aging1999–2002
Mental Health CRC To Study Geriatric SchizophreniaNational Institute Of Mental Health1997–2002
Alzheimers Disease Research CenterNational Center For Research Resources1987–2002
Extramural Research Facilities ConstructionNational Center For Research Resources2001
Alzheimers Disease Research CenterNational Institute On Aging1997–2001
Alzheimers DiseaseNational Institute On Aging1997–1998
Neurochemistry ProjectNational Institute On Aging1994–1998
Amyloid Beta Protein In CSF And Familial Aggregation In Alzheimer'S DiseaseNational Institute On Aging1994–1998
Program In Biological PsychiatryNational Center For Research Resources1995–1996
Alzheimers DiseaseNational Institute On Aging1994–1996
Cellular And Molecular Markers In SchizophreniaNational Center For Research Resources1994–1996
Cellular And Molecular Markers In SchizophreniaNational Institute Of Mental Health1990–1996
Alzheimer'S Disease Research CenterNational Center For Research Resources1992–1993
Noradrenergic Markers In Alzheimer'S DiseaseNational Institute On Aging1989–1993
Alzheimer'S Disease Research CenterNational Institute On Aging1985–1993
Cholinergic Treatment Of Memory Deficits In The AgedNational Center For Research Resources1985–1993
Competitive Supplement To ADRCNational Institute On Aging1992
Supplement To Alzheimer'S Disease Research CenterNational Institute On Aging1991–1992
Toward A Rational Use Of Plasma HVA In Mental IllnessNational Center For Research Resources1990–1991
Cholinergic Treatment Of Memory Deficits In The AgedNational Institute On Aging1985–1989
Plasma HOMA Vanillic Acid (PHVA) Use In Mental IllnessNational Center For Research Resources1985–1989
Drug Treatments Of Noncognitive Behavioral Disturbances In ADNational Institute On Aging1985–1988
Biologically Induced Human Models Of ADNational Institute On Aging1985–1988
Clinical And Biomedical Effects Of Neuroleptic Agents WithdrawalNational Center For Research Resources1985–1988
The Efficacy Of THA In Alzheimer'S DiseaseNational Institute On Aging1987
Toward A Rational Use Of Plasma MVA In Mental IllnessNational Institute Of Mental Health1986–1987
Clinical Markers/Genetic Risks In Alzheimer'S DiseaseNational Institute On Aging1986
RS-86 Treatment Of Alzheimer'S DiseaseNational Center For Research Resources1985–1986